According to a new report Global Intragastric Balloon Market, published by KBV research, The Global Intragastric Balloon Market size is expected to reach $77.5 Million by 2026, rising at a market growth of 12.4% CAGR during the forecast period.
Due to the availability of a large number of products in the market, the single balloon type segment held the largest market share in 2019. The segment of the triple type of balloon is expected to witness lucrative growth over the coming years. The advantages provided by the existing triple balloon system are expected to increase demand for this type of balloons, such as minimal downtime and completely reversible treatment.
With the sudden break of Covid-19 in late months of year 2019, the markets worldwide are unfortunately experiencing its grip. The suppliers and consumers of the products & Services are affected in a big way across the sectors resulting in declining revenues in last quarters of year 2019. The declining trend in market sizes is expected to not only sustain but will also amplify itself in year 2020 hugely disturbing the economies worldwide.
Due to the high accessibility of the product and significant weight loss generated by these intragastric systems, the saline-filled intragastric systems held the dominant market share in 2019. Intragastric balloons filled with gas are expected to witness substantial growth over the forecast period. The reported adverse events due to the use of saline-filled intragastric systems are anticipated to boost the demand for alternatives, such as intragastric balloons filled with gas.
The Hospital segment held the largest market share in 2019. This growth can be associated with the presence of skilled professionals in hospital settings and the existence of advanced equipment. Additionally, the availability of a large number of weight-loss treatment options that require hospital stay is expected to contribute to the growth of the segment.
North America accounted for the biggest market share in terms of revenue in 2019. High prevalence of obesity, the availability of skilled professionals and the high adoption of treatments for weight loss are some of the major factors contributing to market growth in this region. The Asia Pacific region is likely to see explosive growth. Expanding obese population, unhealthy lifestyle, and treatment availability at relatively low cost are some of the key factors driving the intragastric balloon market in the region.
Structural Insights: https://www.kbvresearch.com/intragastric-balloon-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Sientra, Inc. (Silimed, Inc.), Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., ReShape Lifesciences Inc., Allurion Technologies, Inc., Helioscopie SA (Sante Actions Group), Districlass Medical SA, Spatz FGIA, Inc., Duomed Group (Life Partners Europe), Medsil.
By Administration
By Type
By Filling Material
By End Use
By Geography
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
